Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stancek

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Acta Virologica|June 27, 2002
Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2D Stancek, N Fuchsberger, M Oltman, et al.
Acta Virologica|June 8, 1999
Therapy-induced antibodies to interferon-alpha 2a recognise its receptor-binding siteH Liptáková, E Kontseková, P Kabát, et al.
Acta Virologica|September 1, 1990
Immunological markers in patients with different forms of viral hepatitis B treated by "conventional" therapy or with HuIFN alphaD Stancek, S Janota, H Blaskovicová, et al.
Vnitrni Lekarstvi|September 1, 1987
[The asymptomatic carrier state of viral hepatitis B]J Glasa, J Holomán, D Stancek, et al.
Bratislavske Lekarske Listy|September 1, 1992
[Prenatal virus infections and orofacial clefts]A Molnárová, M Brozman, I Schwanzerová, et al.
Acta Virologica|May 1, 1987
Dynamics of serum markers in the different course of hepatitis B virus (HBV) infectionD Stancek, H Blaskovicová, V Hajnická, et al.
Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health|November 8, 2002
Partial sequencing of env gene of bovine leukaemia virus from Brazilian samples and phylogenetic analysisM F Camargos, D Stancek, M A Rocha, et al.
Genetics and Molecular Research : GMR|February 19, 2014
Genetic variation of bovine leukemia virus (BLV) after replication in cell culture and experimental animalsM F Camargos, D S Rajão, R C Leite, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Acta Virologica|June 27, 2002
Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2D Stancek, N Fuchsberger, M Oltman, et al.
Acta Virologica|June 8, 1999
Therapy-induced antibodies to interferon-alpha 2a recognise its receptor-binding siteH Liptáková, E Kontseková, P Kabát, et al.
Acta Virologica|September 1, 1990
Immunological markers in patients with different forms of viral hepatitis B treated by "conventional" therapy or with HuIFN alphaD Stancek, S Janota, H Blaskovicová, et al.
Vnitrni Lekarstvi|September 1, 1987
[The asymptomatic carrier state of viral hepatitis B]J Glasa, J Holomán, D Stancek, et al.
Bratislavske Lekarske Listy|September 1, 1992
[Prenatal virus infections and orofacial clefts]A Molnárová, M Brozman, I Schwanzerová, et al.
Acta Virologica|May 1, 1987
Dynamics of serum markers in the different course of hepatitis B virus (HBV) infectionD Stancek, H Blaskovicová, V Hajnická, et al.
Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health|November 8, 2002
Partial sequencing of env gene of bovine leukaemia virus from Brazilian samples and phylogenetic analysisM F Camargos, D Stancek, M A Rocha, et al.
Genetics and Molecular Research : GMR|February 19, 2014
Genetic variation of bovine leukemia virus (BLV) after replication in cell culture and experimental animalsM F Camargos, D S Rajão, R C Leite, et al.
Pageof 5